Polymorphs and hydrates of the anticancer drug erlotinib: X-ray crystallography, phase transition and biopharmaceutical studies

Shridhar H. Thorat, Christy P. George, Parth S. Shaligram, P. R. Suresha, Rajesh G. Gonnade

CrystEngComm · 2021 · 10 citations · 26 references

Concepts

Abstract

The anticancer drug erlotinib revealed two polymorphs and two hydrates. The metastable polymorph and hydrates converted to the stable polymorph, which displayed solution-mediated transformation into the monohydrate at the lowest water activity.

References

26